α-1-Antichymotrypsin promotes β-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease

Journal of Neuroscience

Volumn 21, Issue 5, 2001, Pages 1444-1451

  Nilsson, Lars N G ^a,b   Bales, Kelly R ^c   DiCarlo, Giovanni ^a   Gordon, Marcia N ^a   Morgan, Dave ^a   Paul, Steven M ^c   Potter, Huntington ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Alzheimer's disease; Amyloid deposition; Amyloid peptide; Congo Red; Inflammation; Transgenic mice; 1 antichymotrypsin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CONGO RED;

AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BETA SHEET; BIREFRINGENCE; CATALYSIS; CONTROLLED STUDY; HIPPOCAMPUS; INFLAMMATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0035282790     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-05-01444.2001     Document Type: Article

References (50)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. 1-antichymotrypsin
3. Inflammation and Alzheimer's disease
4. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
5. V717F transgenic mouse model of Alzheimer's disease
6. Neuroinflammation and Alzheimer's disease: Critical roles for cytokine/Aβ-induced glial activation, NF-κB, and apolipoprotein E
7. A polymorphism in the regulatory region of ApoE associated with risk for Alzheimer's dementia
8. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
9. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1
10. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes
11. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease
12. 1-Antichymotrypsin regulates Alzheimer β-amyloid peptide fibril formation
13. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer's disease
14. 1-Antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro
15. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
16. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
17. Association of early-onset Alzheimer's disease with an Interleukin-1α gene polymorphism
18. Accelerated evolution in the reactive centre regions of serine protease inhibitors
19. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
20. 2-Macroglobulin associates with β-amyloid peptide and prevents fibril formation
21. 1-antichymotrypsin (ACT) protease inhibitor in Alzheimer's disease brain
22. Quantitative analysis of senile plaques in Alzheimer disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome)
23. The murine Spi-2 proteinase inhibitor locus: A multigene family with a hypervariable reactive site domain
24. 1-antichymotrypsin
25. 1-antichymotrypsin and transforms it from in inhibitor to substrate
26. 1-antichymotrypsin polymorphism
27. 1-antichymotrypsin in brain may be related to astrogliosis
28. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
29. Alzheimer A beta neurotoxicity: Promotion by antichymotrypsin. ApoE4; inhibition by A beta-related peptides
30. Anti-inflammatory drugs and Alzheimer disease
31. 1-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice
32. An RNA polymerase II promoter containing sequences upstream and downstream from the RNA startpoint that direct initiation of transcription from the same site
33. Association of interleukin-1 gene polymorphisms with Alzheimer's disease
34. The essential role of inflammation and induced gene expression in the pathogenic pathway of Alzheimer's disease
35. Astrocytes in Alzheimer's disease gray matter express alpha1-antichymotrypsin mRNA
36. The involvment of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease
37. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
38. Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences
39. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform ApoE4 associates more efficiently than ApoE3
40. Identification of a cis-acting positive regulatory element of the glial fibrillary acidic protein gene
41. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
42. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution
43. Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease
44. Glial fibrillary acidic protein-apolipoprotein E (ApoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted ApoE3 and ApoE4 lipoproteins
45. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid
46. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro
47. The prionoses and other conformational disorders
48. Association of the alpha1-antichymotrypsin polymorphism with cerebral amyloid angiopathy
49. Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-beta peptide degradation